---
title: "CXR and Bandim TBScore Weakly Predict Two‑Month Culture Conversion in PTB"
id: "medrxiv-7-tuberculosis-severity-metrics-poorly-predict-two-month-culture-conversion"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-7-tuberculosis-severity-metrics-poorly-predict-two-month-culture-conversion"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.19.26368488v1?rss=1"
published_at: "2026-11-20T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# CXR and Bandim TBScore Weakly Predict Two‑Month Culture Conversion in PTB
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-7-tuberculosis-severity-metrics-poorly-predict-two-month-culture-conversion
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.19.26368488v1?rss=1)
- **Published At:** 2026-11-20T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The Kawempe Community Health Study cohort included 718 pulmonary tuberculosis (PTB) index cases and was analyzed for two‑month **culture conversion**. - Sixty‑eight percent of participants achieved culture conversion at two months; this was the primary outcome reported. - Investigators evaluated two clinical severity metrics: the **CXR Score** and the **Bandim TBScore**, alongside demographics, clinical, microbiological, radiological, household and behavioral variables. - The highest CXR Score category was inversely associated with conversion (odds ratio [OR] 0.51, 95% CI 0.31–0.84), according to the report. - Higher **smear grade** at diagnosis also associated with lower odds of conversion (OR 0.42, 95% CI 0.26–0.62). - Pleural thickening on imaging showed an inverse association (OR 0.41, 95% CI 0.17–0.95), as did current smoking (OR 0.31, 95% CI 0.09–0.99). - Despite these associations, both severity measures and the most parsimonious multivariable model performed poorly for prediction; all reported AUCs were below 0.70. - The authors concluded that the examined severity scores provided limited utility for predicting two‑month culture conversion in this cohort. - The source did not report additional biomarkers, specific predictive cutpoints beyond categories, or external validation analyses; those details were not provided.
## Clinical Analysis & Structured Key Points
Tuberculosis Severity metrics poorly predict Two-Month Culture Conversion | medRxiv Skip to main content Tuberculosis Severity metrics poorly predict Two-Month Culture Conversion View ORCID Profile Lentlametse Mantshonyane , View ORCID Profile Penelope Benchek , LaShaunda Malone , Mary Nsereko , Hussein Kisingo , View ORCID Profile Daniel J. Tisch , View ORCID Profile Fredrick R. Schumacher , View ORCID Profile W. Henry Boom , View ORCID Profile Harriet Mayanja-Kizza , View ORCID Profile Catherine Stein , Scott M. Williams doi: https://doi.org/10.64898/2026.11.19.26368488 Lentlametse Mantshonyane 1 CaseWestern Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Lentlametse Mantshonyane For correspondence: lxm514{at}case.edu Penelope Benchek 2 Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Penelope Benchek LaShaunda Malone 3 Department of Medicine, Division of Infectious Diseases, Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mary Nsereko 4 Makerere University Medical School: Makerere University College of Health Sciences; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hussein Kisingo 4 Makerere University Medical School: Makerere University College of Health Sciences; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Daniel J. Tisch 5 Department of Population and Quantitative Health Sciences, Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Daniel J. Tisch Fredrick R. Schumacher 5 Department of Population and Quantitative Health Sciences, Case Western Reserve University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Fredrick R. Schumacher W. Henry Boom 6 Department of Medicine, Division of Infectious Diseases; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for W. Henry Boom Harriet Mayanja-Kizza 7 Makerere University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Harriet Mayanja-Kizza Catherine Stein 8 Case Western Reserve University,Department of Population and Quantitative Health Sciences,Department of Medicine, Division of Infectious Diseases; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Catherine Stein Scott M. Williams 9 Case Western Reserve University,Department of Population and Quantitative Health Sciences,Department of Medicine,Cleveland Institute for Computational Biology, School of Medicine, Makerere University and Mulago Hospital, Kampala Uganda. Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Data/Code Preview PDF Abstract Abstract Objectives Among people with pulmonary tuberculosis (PTB), culture conversion (bacterial clearance) after two months of treatment is a critical indicator of response. However, predictors of culture conversion at two months are difficult to define and can be context specific. In this study, we evaluated how well two tuberculosis (TB) severity metrics, the chest Xray (CXR) Score and the Bandim TBScore associate with and predict two-month culture conversion. Methods The cohort contained 718 index PTB cases enrolled in The Kawempe Community Health Study (KCHS). We analyzed severity metrics, demographics, clinical, microbiological, radiological, household and behavioral data for their association with and their ability to predict culture conversion. Results Sixty-eight percent of participants culture converted at two months. The highest CXR Score category (odds ratio (OR) 0.51, 95% Confidence Interval (CI) 0.31, 0.84), smear grade at diagnosis (OR 0.42, 95% CI; 0.26, 0.62), pleural thickening (OR 0.41, 95% CI 0.17, 0.95) and current smoking (OR 0.31, 95% CI 0.09, 0.99) inversely associated with conversion. Both severity measures and the most parsimonious model poorly predicted culture conversion (all AUCs<0.70). Conclusion CXR Score, higher smear grade at diagnosis, pleural thickening, and current smoking inversely associated with culture conversion but provided limited utility for prediction. Keywords: Tuberculosis outcomes; Mycobacterium clearance; TB severity scores Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: This study was approved by National HIV/AIDS Research Committee of Makerere University and the institutional review board at University Hospitals, Cleveland Medical Center. Final clearance was given by the Uganda National Council for Science and Technology. Written informed consent was obtained from all study participants. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present study are available upon reasonable request to the authors Funder Information Declared Tuberculosis Research Unit at the National Institutes of Health , N01-AI95383 National Institute of Allergy and Infectious Diseases , HHSN266200700022C/N01-AI70022 , U19AI162583 Burroughs Wellcome Fund, https://ror.org/01d35cw23 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted November 20, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Tuberculosis Severity metrics poorly predict Two-Month Culture Conversion Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Tuberculosis Severity metrics poorly predict Two-Month Culture Conversion Lentlametse Mantshonyane , Penelope Benchek , LaShaunda Malone , Mary Nsereko , Hussein Kisingo , Daniel J. Tisch , Fredrick R. Schumacher , W. Henry Boom , Harriet Mayanja-Kizza , Catherine Stein , Scott M. Williams medRxiv 2026.11.19.26368488; doi: https://doi.org/10.64898/2026.11.19.26368488 Share This Article: Copy Citation Tools Tuberculosis Severity metrics poorly predict Two-Month Culture Conversion Lentlametse Mantshonyane , Penelope Benchek , LaShaunda Malone , Mary Nsereko , Hussein Kisingo , Daniel J. Tisch , Fredrick R. Schumacher , W. Henry Boom , Harriet Mayanja-Kizza , Catherine Stein , Scott M. Williams medRxiv 2026.11.19.26368488; doi: https://doi.org/10.64898/2026.11.19.26368488 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Epidemiology Subject Areas All Articles Addiction Medicine (642) Allergy and Immunology (928) Anesthesia (355) Cardiovascular Medicine (5060) Dentistry and Oral Medicine (496) Dermatology (433) Emergency Medicine (681) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1704) Epidemiology (16353) Forensic Medicine (37) Gastroenterology (1250) Genetic and Genomic Medicine (7334) Geriatric Medicine (761) Health Economics (1101) Health Informatics (5352) Health Policy (1480) Health Systems and Quality Improvement (1847) Hematology (604) HIV/AIDS (1389) Infectious Diseases (except HIV/AIDS) (16537) Intensive Care and Critical Care Medicine (1210) Medical Education (702) Medical Ethics (157) Nephrology (757) Neurology (7669) Nursing (380) Nutrition (1144) Obstetrics and Gynecology (1308) Occupational and Environmental Health (1046) Oncology (3769) Ophthalmology (1105) Orthopedics (414) Otolaryngology (474) Pain Medicine (508) Palliative Medicine (144) Pathology (727) Pediatrics (1877) Pharmacology and Therapeutics (759) Primary Care Research (793) Psychiatry and Clinical Psychology (6187) Public and Global Health (10051) Radiology and Imaging (2562) Rehabilitation Medicine and Physical Therapy (1540) Respiratory Medicine (1280) Rheumatology (666) Sexual and Reproductive Health (814) Sports Medicine (601) Surgery (809) Toxicology (109) Transplantation (321) Urology (309)
## Related Clinical Research

- [Impact of loss to follow-up on 5-year mortality after tuberculosis treatment in São Paulo, Brazil](https://medichelpline.com/clinical-feed/plos-medicine-0-loss-to-follow-up-during-tuberculosis-treatment-and-5-year-mortality-in-brazil.md)
- [SARS-CoV-2 antibody landscape after multiple Omicron-era vaccinations and infections](https://medichelpline.com/clinical-feed/medrxiv-23-sars-cov-2-antibody-landscape-following-multiple-vaccinations-and-infections.md)
- [Ontario TB Presentations Rose During the Pandemic Era but Not After Community SARS-CoV-2 Activity](https://medichelpline.com/clinical-feed/medrxiv-10-rising-tuberculosis-presentations-in-ontario-canada-are-not-explained-by.md)
- [Self-reported tuberculosis prevalence and vulnerability factors in six rural Indian districts](https://medichelpline.com/clinical-feed/plos-one-16-self-reported-prevalence-of-tuberculosis-and-selected-associated-vulnerability.md)
- [Understanding Parasitic Identification in Delusional Parasitosis](https://medichelpline.com/clinical-feed/plos-one-21-bridging-perception-and-reality-parasitic-identification-in-delusional.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.